SECreport

Form 4 Global Blood Therapeutic For: Oct 01 Filed by: JOHNSON DAVID LEE

Global Blood Therapeutics, Inc.  (GBT) 
NASDAQ:AMEX Investor Relations: ir.globalbloodtx.com